US Edition
Shining a Spotlight on More Effective Treatments for HER2+ MBC
Summary by komen.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Shining a Spotlight on More Effective Treatments for HER2+ MBC
Despite important advances in breast cancer treatment, the disease can still find ways to outsmart even the best therapies. People living with HER2-positive metastatic breast cancer (HER2+ MBC) often respond well to treatments at first, with tumors shrinking or slowing down, but the effectiveness of these drugs doesn’t always last. Through the EmpowHER-303 clinical trial (NCT06435429), researchers are shining a spotlight on more effective treatm…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
